PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 22.50
+0.45 (2.04%)
Jul 21, 2025, 5:30 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 727.57 million as of July 21, 2025. Its market cap has decreased by -23.11% in one year.
Market Cap
727.57M
Enterprise Value
761.92M
Revenue
315.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.50
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 727.57M, a decrease of -71.91%. That is a compound annual growth rate of -25.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 727.57M | -22.33% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 207.20B |
| Novartis AG | 178.66B |
| Lonza Group AG | 40.25B |
| Alcon | 34.77B |
| Galderma Group AG | 30.22B |
| Sandoz Group AG | 19.71B |
| Straumann Holding AG | 16.86B |
| Sonova Holding AG | 14.00B |